History
The patient is a 54-year-old man with a history of a nonischemic dilated cardiomyopathy. He was initially referred for consideration of a third procedure for atrial fibrillation. He had undergone pulmonary vein isolation procedures 1 year and 3 months previously. In addition to pulmonary vein isolation, linear ablation of both the left and right atria had been performed, as well as targeting of complex fractionated atrial electrograms. Despite this, the patient experienced early recurrences of atrial fibrillation and atypical atrial flutter soon after each ablation. In addition, amiodarone, digoxin, and beta blockade were used as adjunctive therapy, yet rate control remained poor. Heart rates during waking hours averaged approximately 110 bpm. Left ventricular systolic function was globally reduced, and the ejection fraction was estimated to be approximately 20%. His symptom was New York Heart Association (NYHA) class II to III dyspnea, yet he had no history of hospital admissions for heart failure, no palpitations, and no presyncopal symptoms.
The patient had failed an antiarrhythmic strategy using a combination of medication and ablation. Furthermore, he was failing a rate control strategy using three different atrioventricular nodal blocking agents. He remained tachycardic and symptomatic, and therefore the following therapeutic options were discussed with him and his family: (1) a third catheter ablation for atrial fibrillation, (2) permanent pacemaker implantation with adjunctive atrioventricular nodal ablation, and (3) open surgical cut-and-sew maze procedure. The patient elected to proceed with atrioventricular nodal ablation and permanent pacemaker implantation.
Current Medications
The patient was taking digoxin 250 mcg daily, furosemide 20 mg daily, losartan 50 mg daily, amiodarone 300 mg daily, metoprolol 100 mg twice daily, spironolactone 25 mg daily, and warfarin to maintain international normalized ratio between 2 and 3.
Current Symptoms
The patient’s predominant symptom was dyspnea on exertion. His exercise tolerance was limited to flat surfaces. In addition, he was frequently becoming dyspneic with simple activities of daily living while working on his farm. He had not had any syncopal episodes and was not aware of any palpitations.
Physical Examination
Laboratory Data
Electrocardiogram
Findings
Figure 25-1 shows the electrocardiogram (ECG) obtained before device implantation. The rhythm is atrial fibrillation with a fairly rapid ventricular response. The QRS duration is less than 100 ms, and no evidence of acute ischemia is present.
Figure 25-2 shows the ECG obtained after atrioventricular node ablation and device implantation. The rhythm is atrial fibrillation, with evidence of biventricular pacing. Frequent premature ventricular contractions occurred, with varying degrees of fusion.
Chest Radiograph
Findings
The chest radiograph showed the heart size to be normal. Mild pulmonary venous hypertension was noted (Figure 25-3).
Echocardiogram
Findings
Buy Membership for Cardiovascular Category to continue reading. Learn more here
Related posts:
20. Novel Wireless Technologies for Endocardial Cardiac Resynchronization Therapy
36. Cardiac Resynchronization Therapy in Non–Left Bundle Branch Block Morphology
23. Left Ventricular Quadripolar Lead in Phrenic Nerve Stimulation
31. Resumption to Sinus Rhythm After Cardiac Resynchronization Therapy in a Patient with Long-Lasting Persistent Atrial Fibrillation
43. Recognition of Anodal Stimulation
49. Role of Remote Monitoring in Managing a Patient on Cardiac Resynchronization Therapy
